- Title
- COBRA: Assessment of safety and efficacy of Cu-SAR-bisPSMA in patients with biochemical recurrence of prostate cancer following definitive therapy
- Creators
- Luke Nordquist - XCancer Omaha, Omaha, NE, United StatesEva Lengyelova - Clarity Pharmaceuticals, Eveleigh, NSW, AustraliaDaniel Saltzstein - Urology San AntonioDavid Josephson - Tower Urology Medical GroupGregg E. Franklin - New Mexico Cancer CenterGlynn Morrish - Clarity Pharmaceuticals, Eveleigh, NSW, AustraliaOthon Gervasio - Clarity Pharmaceuticals, Eveleigh, NSW, AustraliaMichelle Parker - Clarity Pharmaceuticals, Eveleigh, NSW, AustraliaRobert M. Miller - Clarity Pharmaceuticals, Eveleigh, NSW, AustraliaNeal D. Shore - Carolina Urologic Research Center
- Publication Details
- Journal of clinical oncology, Vol.42, pp.5100-5100
- Identifiers
- 991006262532302656
- Academic Unit
- Radiology
- Language
- English
- Resource Type
- Journal article
Journal article
COBRA: Assessment of safety and efficacy of Cu-SAR-bisPSMA in patients with biochemical recurrence of prostate cancer following definitive therapy
Journal of clinical oncology, Vol.42, pp.5100-5100
06/01/2024
Metrics
1 Record Views